| Literature DB >> 31686898 |
Naoto Takahashi1,2, Kozue Takatsuki1, Satoshi Kasahara1,2, Shoji Yabuki1,2.
Abstract
INTRODUCTION: Multidisciplinary pain management is a useful method for treating chronic musculoskeletal pain. Currently, few facilities in Japan offer multidisciplinary pain treatment, especially in the inpatient setting. We implemented a multidisciplinary pain management program based on International Association for the Study of Pain recommendations. This study described our initial efforts in implementing the program, and reported 3- and 6-month follow-up results.Entities:
Keywords: biopsychosocial model; chronic musculoskeletal pain; inpatient pain management program; multidisciplinary pain treatment
Year: 2019 PMID: 31686898 PMCID: PMC6708881 DOI: 10.2147/JPR.S212205
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Flowchart for the evaluation and diagnosis of chronic musculoskeletal pain at Hoshi General Hospital. First, orthopedic surgeons evaluate physical, neurological, and imaging findings and diagnose the presence of any specific musculoskeletal disorders. Second, physical therapists evaluate physical function. Third, psychiatrists diagnose any psychological disorders associated with chronic musculoskeletal pain, including psychiatric disorders. Fourth, clinical psychologists evaluate the psychosocial factors associated with pain. Finally, we perform brain magnetic resonance imaging and cerebral blood-flow scintigraphy to evaluate cortical function.
Abbreviations: MPI, Multidimensional Pain Inventory; CAARS, Conners' Adult ADHD Rating Scales.
Characteristics of the 23 cases
| Case | Chief complaint | Structural disorder | Psychiatric diagnosis |
|---|---|---|---|
| 2. 53-year-old woman | Posterior cervical pain, bilateral omalgia, low back pain | None | Dependent personality disorder, somatoform disorders |
| 4. 55-year-old woman | Posterior cervical pain, bilateral upper extremity numbness | Ossification of posterior longitudinal ligament (after surgery) | Narcissistic personality disorder |
| 6. 56-year-old woman | Posterior cervical pain, bilateral omalgia, low back pain, bilateral gonalgia | Spondylosis, knee osteoarthritis | Attention deficit hyperactivity disorder, dependent personality disorder, somatoform disorders |
| 8. 47-year-old woman | Low back pain | None | Attention deficit hyperactivity disorder, histrionicism personality disorder, somatoform disorders |
| 10. 51-year-old man | Low back pain | None | Pervasive developmental disorder, attention deficit hyperactivity disorder, somatoform disorders |
| 12. 58-year-old woman | Posterior cervical pain, bilateral omalgia, low back pain, right coxalgia, bilateral gonalgia, bilateral leg pain | Right-hip osteoarthritis, 4th lumbar degenerative spondylolisthesis | Pervasive developmental disorder, attention deficit hyperactivity disorder, somatoform disorders |
| 13. 75-year-old woman | Low back pain, bilateral leg pain | Spondylosis | None |
| 14. 73-year-old woman | Low back pain, bilateral leg pain | Spondylosis, scoliosis | None |
| 15. 68-year-old woman | Back pain, low back pain, bilateral leg pain | Spondylosis, ossification of yellow ligament (after surgery) | None |
| 16. 34-year-old man | Low back pain | None | Pervasive developmental disorder, attention deficit hyperactivity disorder, somatoform disorders |
| 17. 79-year-old man | Posterior cervical pain, left-arm pain, low back pain, bilateral leg pain | Spondylosis | Pervasive developmental disorder, attention deficit hyperactivity disorder, compulsive personality disorder, somatoform disorders |
| 18. 42-year-old woman | Bilateral sole numbness, cool feeling, and burning sensation | None | Pervasive developmental disorder, attention deficit hyperactivity disorder, somatoform disorders |
| 19. 42-year-old woman | Low back pain | None | Pervasive developmental disorder, attention deficit hyperactivity disorder, somatoform disorders |
| 20. 53-year-old woman | Low back pain | Spondylosis | Pervasive developmental disorder, attention deficit hyperactivity disorder, somatoform disorders |
| 21. 40-year-old man | Low back pain, bilateral sacroiliac joint pain | None | None |
Notes: Eight patients (four males, four females) aged 20–69 years (mean age 42.9 years) were also evaluated at 3 and 6 months after the program (marked by bold font in Table 1). Statistically significant improvement was seen in pain and associated factors (Figure 2) and physical functions (Figure 3).
Figure 2Changes in pain-associated factors. Statistically significant improvement was seen in: PCS (rumination) at 3 (p=0.03) and 6 (p=0.003) months after the program; PCS (helplessness) at 3 (p=0.012) and 6 (p=0.04) months; PDAS at 6 months (p=0.04); HADS (anxiety) at 6 months (p=0.016); and PSEQ immediately after (p=0.004), at 3 months (p=0.012), and at 6 months (p=0.03). *p<0.05.
Abbreviations: BPI, Brief Pain Inventory; PCS, Pain Catastrophizing Scale; PDAS, Pain Disability Assessment Scale; HADS, Hospital Anxiety and Depression Scale; PSEQ, Pain Self-Efficacy Questionnaire; EQ-5D, EuroQol Five Dimensions Questionnaire.
Figure 3Changes in physical ability. Statistically significant improvement was seen in finger-floor distance (FFD) (flexibility) at 3 (p=0.04) and 6 (p=0.04) months after the program, and the 30-second sit-to-stand test (muscle endurance) at 6 months (p=0.012). *p<0.05.
Changes in pain and associated factors (n=23)
| Before program | Immediately after program | |||
|---|---|---|---|---|
| BPI | 24.5±10.15 | 20.0±8.90 | 0.0001 | 0.73 |
| PCS (rumination) | 15.1±5.19 | 12.7±5.21 | 0.004 | 0.58 |
| PCS (magnification) | 6.3±4.09 | 4.4±3.53 | 0.001 | 0.67 |
| PCS (helplessness) | 11.5±5.58 | 7.5±5.67 | 0.0001 | 0.68 |
| PCS (total) | 32.7±14.05 | 24.5±13.68 | 0.0001 | 0.71 |
| PDAS | 29.4±12.29 | 18.8±12.56 | 0.001 | 0.64 |
| HADS (anxiety) | 8.7±4.86 | 6.2±4.02 | 0.0001 | 0.66 |
| HADS (depression) | 9.8±4.81 | 6.5±4.35 | 0.001 | 0.65 |
| PSEQ | 22.1±11.90 | 33.2±13.93 | 0.0001 | 0.69 |
| EQ-5D | 0.533±0.1552 | 0.641±0.1745 | 0.009 | 0.53 |
Notes: p-values less than 0.05 were considered statistically significant. r shows the effect size between before and immediately after the program. The cut-off value for the PCS total score is 30 points. The PCS total score was >30 points before the program and <30 points immediately after program. The result suggested the PCS total score improved more than the minimal detectable change. The PDAS cut-off value is 10 points. The PDAS was >10 points before and immediately after program. The result suggested PDAS scores might not have improved to normal condition; however, the PDAS showed significant improvement immediately after the program. For the HADS, 8–10 points indicates suspicion of anxiety/depression and >11 points indicates anxiety/depression. The result suggested HADS scores improved more than the minimal detectable change. The minimal clinically important difference for the PSEQ is >9%. The result suggested PSEQ scores improved more than the minimal detectable change. The BPI and EQ-5D have no clear standards; however, these results suggested pain severity (BPI) and quality of life (EQ-5D) improved immediately after the program.
Abbreviations: SD, standard deviation; BPI, Brief Pain Inventory; PCS, Pain Catastrophizing Scale; PDAS, Pain Disability Assessment Scale; HADS, Hospital Anxiety and Depression Scale; PSEQ, Pain Self-Efficacy Questionnaire; EQ-5D, EuroQol Five Dimensions Questionnaire.
Changes in physical functions (n=23)
| Before program (mean ± SD) | Immediately after program | |||
|---|---|---|---|---|
| Finger floor distance (flexibility) | 15.8±16.30 | 8.1±13.73 | 0.005 | 0.59 |
| 30-second sit-to-stand test (muscle endurance) | 14.0±7.46 | 18.9±8.87 | 0.0001 | 0.77 |
| 2-step test (walking ability) | 1.3±0.27 | 1.4±0.23 | 0.01 | 0.53 |
| 6 mins walking (physical fitness) | 424.9±127.64 | 477.0±133.96 | 0.005 | 0.59 |
Notes: p-values less than 0.05 were considered statistically significant. r shows the effect size between before and immediately after the program.
Abbreviation: SD, standard deviation.
Outcomes at follow-up after inpatient programs in other countries
| Outcome | Outcome immediately after program | Outcome at follow-up | Follow-up rate (%) | |
|---|---|---|---|---|
| Pain Treatment Center, Red Cross Hospital (Kassel, Germany) | NRS | Significant post treatment improvement in pain intensity, disability, pain acceptance, catastrophizing, and depression. | 3 months: maintained well | Not listed |
| MPSS | ||||
| PDI | ||||
| ADS-K | ||||
| CPAQ | ||||
| PCS-H | ||||
| HRC Bethesda Children’s Hospital (Budapest, Hungary) | VAS | Short- and long-term improvements in clinical outcomes and resource use among pediatric patients with severe chronic pain. | 3 months: maintained well | 62.5% |
| PPDI | ||||
| CDI | 2 years: maintained well | |||
| CBCQ | ||||
| WCI | ||||
| LTS | ||||
| James A. Haley Veterans’ Hospital (Tampa, FL, USA) | NRS | Significant improvements in pain intensity, pain-related fear, | 3 months: maintained well | Not listed |
| POQ-VA | ||||
| SIS | ||||
| CSQ | ||||
| SPQ | mobility, pain-related negative affect, vitality, implausible symptoms, and sleep. | |||
| Lillehammer Hospital for Rheumatic Diseases (Lillehammer, Norway) | CHQ20 | Self-management program had no effect on psychological distress, functional and symptomatic consequences and self-efficacy, but a small short-term effect on skills/behavior important for managing and participating in healthcare. | 3 weeks: maintained well | 80.3% |
| EC-17 | ||||
| ASES | ||||
| FIQ | ||||
| VAS | ||||
| Pain Centre of the University Medical Centre Groningen (Groningen, the Netherlands) | VAS | Significant improvements in pain, fatigue, walking distance, muscle strength, anxiety, depression, somatization, negative self-efficacy, and catastrophizing in the intervention period. | 6 months: maintained well | 76% |
| 6 min walking test | ||||
| SCL-90 | ||||
| RAND-36 | ||||
| PCL | ||||
| TSK | ||||
| Department of Rheumatology and Physical Medicine, University Hospital of Zurich (Zurich, Switzerland) | MPI | Pain intensity (MPI) and depression (HADS) worsened slightly during 5 months. | 5 months: Pain intensity and depression worsened slightly, but the other outcomes remained almost stable (follow-up at other facilities). | 71.8% |
| SF-36 | ||||
| HADS | ||||
| CSQ | ||||
| INPUT Pain Management, St Thomas’ Hospital (London, UK) | Dysfunction score (SIP) (%) | Outcome measures: QOL, physical performance, pain intensity, and distress, depression severity and confidence; significant improvements immediately after treatment. | 6 months: maintained well | 71.1% |
| Loreley Hospital of Conservative Orthopaedics and Center for Musculoskeletal Medicine, (Loreley, Germany) | NRS | Significant improvements in pain intensity, QOL, and function. | 6 months: maintained well | 53.4% |
| CPI | ||||
| ODI |
Abbreviations: NRS, Numerical Rating Scale; MPSS, Mainz Pain Staging System; PDI, Pain Disability Index; ADS-K, Allgemeine Depressions Skala-Kurz version; CPAQ, Chronic Pain Acceptance Questionnaire; PCS, Pain Catastrophizing Scale; PCS-H, Pain Catastrophizing Scale-helplessness; VAS, Visual Analog Scale; PPDI, Pediatric Pain Disability Inventory; CDI, Children Depression Inventory; CBCQ, Child Behavior Checklist Questionnaire; WCI, the Ways of Coping Inventory; LTS, Likert-type scale; POQ-VA, the Pain Outcome Questionnaire-Department of Veterans Affairs; SIS, Symptom Implausibility Scale; CSQ, Coping Strategy Questionnaire; SPQ, Sleep Problems Questionnaire; CHQ20, General Health Questionnaire 20, EC-17, Effective Musculoskeletal Consumer Scale; ASES, Arthritis Self-Efficacy Scale; FIQ, Fibromyalgia Impact Questionnaire; SCL-90, Symptom Check List-90; PCL, Pain Cognition List; TSK, Tampa Scale for Kinesiophobia; MPI, Multidimensional Pain Inventory; SF-36, Short-Form 36 Questionnaire (SF-36); HADS, Hospital Anxiety and Depression Scale; SIP, Sickness Impact Profile; BDI, Beck Depression Inventory; PSEQ, Pain Self-Efficacy Questionnaire; CPI, Von Korff Questionnaire; ODI, Oswestry Low Back Pain Disability Index; QOL, quality of life.